Skip to main content

Human Health

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation. With a pipeline of around 100 clinical and pre-clinical projects, and the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance.

scientists in laboratory
our pipeline

Our Human Pharma Research and Development Pipeline

With a pipeline of around 100 clinical and pre-clinical projects, and the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance.

Read more
three people gathered around a laptop

Funding Opportunities

Research, Education and Community Funding Opportunities Boehringer Ingelheim recognizes the innovation taking place across communities and wishes to share its success with those reaching for the same goals.

Read more

Latest Articles on Human Health

dna helix graphic
Human Health Innovation

Welcome to Innovation @ Boehringer Ingelheim

Find out how we’re translating new ideas and new science into breakthrough medicines at Boehringer Ingelheim.
Read more
how we discover banner
Fostering Science | Boehringer Ingelheim US

Research and Development

As a global pharmaceutical company, the discovery and development of innovative medicines is fundamental to our continued growth and success.
Read more

Press Releases